Specialty OB/GYN
-
Featured
Innovative Research on Modifying Vaginal Microbiome to Treat Bacterial Vaginosis
The MOTIF clinical trial, led by Caroline Mitchell, MD, MPH, in the Department of Obstetrics and Gynecology at Massachusetts General Hospital, evaluates vaginal fluid transplantation as a preventive therapy for recurrent bacterial vaginosis.
-
Featured
Recommendations for Conducting Health Equity Morbidity and Mortality Conferences
Allison S. Bryant, MD, MPH, and Erin Bradley, MD, of the Department of Obstetrics and Gynecology at Massachusetts General Hospital, and colleagues from four other academic medical centers, outline 10 recommendations for implementing successful health equity morbidity and mortality conferences.
-
Featured
Studying SARS-CoV-2 and mRNA Vaccines in Mothers and Babies
Researchers at Mass General are studying the effects of SARS-CoV-2 infection and mRNA vaccines in pregnant and lactating individuals, as well as neonates.
-
Obstetric Units Can Be Used Efficiently As Remdesivir Infusion Sites for Pregnant and Postpartum Outpatients
Ilona T. Goldfarb, MD, MPH, and colleagues designed a feasible approach for using labor and delivery units to administer three consecutive days of intravenous remdesivir to pregnant and lactating outpatients with mild-to-moderate COVID-19 who were at high risk of developing severe disease.
-
Fentanyl in Labor Epidural Can Affect Results of Maternal and Neonatal Toxicology Tests
Molly R. Siegel, MD, and Sarah N. Bernstein, MD, demonstrated when fentanyl is given as part of the labor epidural, up to 91% of maternal toxicology tests and up to 80% of neonatal tests are positive for the drug. Care should be taken in interpreting toxicology results to avoid false assumptions of non-prescribed use.
-
Digital Therapeutic That Guides Pelvic Floor Muscle Training Demonstrates Real-World Effectiveness
Mass General researchers gathered "real-world" data on the leva Pelvic Health System for guiding pelvic floor muscle training. They found 78% of users reported improvement in symptoms within eight weeks, and 62% met or exceeded the minimum clinically important difference on the Urogenital Distress Inventory.
OB/GYN Contributors
-
Andrea Edlow, MD, MSc
Maternal-Fetal Medicine Specialist , Investigator, Vincent Center for Reproductive Biology
Recent Article
COVID-19 Vaccination During Pregnancy Produces Durable Antibodies in Young Infants
-
Caroline M. Mitchell, MD
Director, Vulvovaginal Disorders Program, Investigator, Vincent Center for Reproductive Biology , Assistant Professor, Obstetrics, Gynecology & Reproductive Biology
Recent Article
Innovative Research on Modifying Vaginal Microbiome to Treat Bacterial Vaginosis
-
Ilona T. Goldfarb, MD, MPH
Maternal Fetal Medicine Specialist, Massachusetts General Hospital
Recent Article
Obstetric Units Can Be Used Efficiently As Remdesivir Infusion Sites for Pregnant and Postpartum Outpatients
-
Irene C. Souter, MD
Director, Preimplantation Genetic Diagnostics Program, Physician, Fertility Center
Recent Article
New Personalized Tool Predicts Pregnancy After Ovulation Induction or Controlled Ovarian Stimulation
-
Jeffrey L. Ecker, MD
Chief, Department of Obstetrics & Gynecology
Recent Article
Mass General Department of OB/GYN Develops and Executes Three-Pronged Diversity Strategy
-
John Petrozza, MD
Chief, Division of Reproductive Medicine and IVF, Director, Massachusetts General Fertility Center, Co-director, Integrated Fibroid Program
Recent Article
Exploring Advances in Fertility Research and Access to Care
-
Marcela G. del Carmen, MD
Chief Medical Officer, Massachusetts General Physicians Organization and Massachusetts General Hospital, Gynecologic Oncologist, Department of Obstetrics and Gynecology, Clinician, Center for Gynecologic Oncology, Mass General Cancer Center
Recent Article
Review: Lesions of the Ovary and Fallopian Tube
-
Mark Clapp, MD
Specialist in the Maternal-Fetal Medicine Program, Massachusetts General Hospital
Recent Article
Natural Language Processing of Admission Notes at Delivery Predicts Severe Maternal Morbidity
-
May M. Wakamatsu, MD
Director, Female Pelvic Medicine & Reconstructive Surgery, Vice Chair, Gynecology
Recent Article
IMPACT: A Standardized Tool for Assessment of Pelvic Floor Disorders
-
Milena M. Weinstein, MD
Director of Research, Female Pelvic Medicine and Reconstructive Surgery Fellowship, Co-director, Center for Pelvic Floor Disorders
Recent Article
Digital Therapeutic That Guides Pelvic Floor Muscle Training Demonstrates Real-World Effectiveness
-
Sarah N. Bernstein, MD
Maternal-Fetal Medicine Specialist, Medical director, Outpatient Obstetrics Program
Recent Article
Fentanyl in Labor Epidural Can Affect Results of Maternal and Neonatal Toxicology Tests
-
William H. Barth, MD
Vice Chair, Obstetrics
Recent Article
Percutaneous Valve Replacement Therapy Sometimes an Option During Pregnancy
Obstetrics & Gynecology Care at Mass General
The Mass General Department of Obstetrics & Gynecology offers the highest level of care to women. Our clinical and research team is a leader in advancing treatments for gynecologic cancers, menopause, high-risk obstetrics, infertility and urogynecology.